ARTICLE | Clinical News
Alfacell preclinical data
May 15, 2006 7:00 AM UTC
In a rat model of glioma, intracranial administration of the controlled-release AC 03-636 polymer formulation significantly prolonged survival with a median survival of 21 days vs. 14 days with contro...